Function of the type V transforming growth factor beta receptor in transforming growth factor beta-induced growth

Q Liu1, S S Huang, J S Huang

  • 1Department of Biochemistry and Molecular Biology, St. Louis University School of Medicine, St. Louis, Missouri 63104, USA.

Insights

Type V transforming growth factor beta (TGF-beta) receptor mediates TGF-beta growth inhibition, even without type I or II receptors. Loss of this receptor may link to carcinoma cell malignancy.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Oncology

Background:

  • Type V transforming growth factor beta (TGF-beta) is a membrane protein co-expressed with TGF-beta receptors.
  • Type V TGF-beta receptor possesses Ser/Thr-specific protein kinase activity.

Purpose of the Study:

  • To investigate the role of the type V TGF-beta receptor in TGF-beta signaling and cellular response.
  • To determine if type V TGF-beta receptor can mediate TGF-beta-induced growth inhibition independently of type I or II receptors.

Main Methods:

  • Immunoprecipitation and metabolic labeling in mink lung epithelial cells.
  • Affinity labeling with 125I-TGF-beta.
  • Cell growth inhibition assays with TGF-beta stimulation.

Main Results:

  • Type V TGF-beta receptor forms heterocomplexes with type I TGF-beta receptor.
  • Kinase activity of type V TGF-beta receptor is stimulated by TGF-beta.
  • TGF-beta induced growth inhibition in wild-type cells and mutants, with higher concentrations needed for mutants.
  • Human colorectal carcinoma cells lacking type V TGF-beta receptor did not show TGF-beta-induced growth inhibition.

Conclusions:

  • Type V TGF-beta receptor can mediate TGF-beta-induced growth inhibition independently of type I or II TGF-beta receptors.
  • Loss of type V TGF-beta receptor function may contribute to the development of certain carcinoma malignancies.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...